Home Cart 0 Sign in  
X

[ CAS No. 5394-18-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 5394-18-3
Chemical Structure| 5394-18-3
Chemical Structure| 5394-18-3
Structure of 5394-18-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 5394-18-3 ]

Related Doc. of [ 5394-18-3 ]

Alternatived Products of [ 5394-18-3 ]

Product Details of [ 5394-18-3 ]

CAS No. :5394-18-3 MDL No. :MFCD00005905
Formula : C12H12BrNO2 Boiling Point : -
Linear Structure Formula :- InChI Key :UXFWTIGUWHJKDD-UHFFFAOYSA-N
M.W : 282.13 Pubchem ID :93575
Synonyms :

Calculated chemistry of [ 5394-18-3 ]

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.33
Num. rotatable bonds : 4
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 69.01
TPSA : 37.38 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.92 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.44
Log Po/w (XLOGP3) : 2.96
Log Po/w (WLOGP) : 2.08
Log Po/w (MLOGP) : 2.44
Log Po/w (SILICOS-IT) : 2.97
Consensus Log Po/w : 2.58

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.47
Solubility : 0.0961 mg/ml ; 0.000341 mol/l
Class : Soluble
Log S (Ali) : -3.41
Solubility : 0.11 mg/ml ; 0.000391 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.53
Solubility : 0.00833 mg/ml ; 0.0000295 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 1.75

Safety of [ 5394-18-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 5394-18-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 5394-18-3 ]
  • Downstream synthetic route of [ 5394-18-3 ]

[ 5394-18-3 ] Synthesis Path-Upstream   1~12

  • 1
  • [ 110-52-1 ]
  • [ 136918-14-4 ]
  • [ 5394-18-3 ]
YieldReaction ConditionsOperation in experiment
92% With potassium carbonate In acetone for 2 h; Reflux Phthalimide 6a (148mg, 1mmol), 124 1,4-dibromobutane (1.080g, 5mmol), 12 potassium carbonate (276mg, 2mmol) was added to 115 acetone (3mL), and the reaction mixture was refluxed for 2h. After cooling to room temperature, the reaction mixture was purified by column chromatography using 125 PE: acetone (40:1) as eluent to give 126 7a (260mg, 92percent) as a white solid.
86% With potassium carbonate In acetone at 50℃; for 12 h; Phthalimide (3.20 g, 0.05 mmol) was dissolved in acetone (40 mL), potassium carbonate (10.4 g, 0.15 mmol), 1,4-dibromobutane (9.1 mL, 0.15 mmol), 50 The reaction was carried out at ° C for 12 h, and the reaction was complete by TLC.The reaction mixture was concentrated under reduced vacuo.The organic layer was combined, dried over anhydrous sodium sulfateColumn chromatography (petroleum ether: ethyl acetate = 3:1) gave N-(4-bromobutyl)phthalimide (6.10 g, 86percent).
83% With 18-crown-6 ether; potassium carbonate In toluene at 111℃; for 24 h; Inert atmosphere General procedure: To the solution of an imide of general structure B in dry toluene anhydrous K2CO3 (2.5 equiv), 18-crown-6 (1 mol percent) and 1,4-dibromobutane (4 equiv) were added. The reaction mixture was stirred under reflux for 24 h under inert gas. Then, the reaction mixture was filtered off and the filter cake washed with dichloromethane. The combined filtrates were evaporated under reduced pressure and crude product was distilled under reduced pressure.
83% With N-benzyl-N,N,N-triethylammonium chloride; potassium carbonate In acetone at 20℃; for 24 h; Phthalimide (1.176 g, 7.98 mmol), K2CO3 (3.316 g, 24 mmol) and benzyltriethylammonium chloride (200 mg, 0.88 mmol) were dissolved in acetone (20 mL), A mixture of 1,4-dibromobutane (2.9 mL, 24 mmol) was added and stirred for 24 h at room temperature. The solvent was evaporated off, the residue was dissolved in water and DCM, the organic phase was separated, the aqueous layer was extracted twice more with DCM, and the organic layers were combined. It was dried over anhydrous sodium sulfate and concentrated by filtration. The residue was purified by column chromatography to give the title compound (1.861 g, yield: 83percent) as a colorless solid.
83% With potassium carbonate In acetonitrile for 24 h; Reflux General procedure: Compound 6–9 was prepared according the literature reported by Cheng L etal. [34] and with some modifications. Namely, phthalimide (2.9g, 20mmol) and the appropriate dibromoalkanes (80mmol) were added into MeCN (50mL). After an addition of K2CO3 (11g, 80mmol), the mixture was refluxed for 24h and followed by TLC (Thin Layer Chromatography). The solvent was evaporated under reduced pressure, and then the residuum was dissolved in ethyl acetate (200mL) and washed by water (3×100 mL). The organic phase was dried by MgSO4, and then was evaporated. The crude product was purified by column chromatography (PE/EtOAc=10:1, Rf=0.4) to give 6–9.
62.3% With potassium carbonate In acetone at 20℃; for 10 h; 0.1 part of 1,4-dibromobutane, 0.1 part of benzoxazole carboxylate and 0.3 part of potassium carbonatewere mixed into the reacion flask. 20 parts of acetine was added and reacted at room temperature for 10 hours.Filtration and drying were carried out to collect compound 1 in 62.3 percent yield.

Reference: [1] Journal of Organic Chemistry, 2004, vol. 69, # 18, p. 6094 - 6099
[2] Angewandte Chemie - International Edition, 2018, vol. 57, # 6, p. 1532 - 1536[3] Angew. Chem., 2018, vol. 130, # 6, p. 1548 - 1552,5
[4] European Journal of Medicinal Chemistry, 2018, vol. 145, p. 74 - 85
[5] Journal of the Chinese Chemical Society, 2013, vol. 60, # 12, p. 1431 - 1436
[6] Patent: CN108383892, 2018, A, . Location in patent: Paragraph 0088; 0089
[7] European Journal of Medicinal Chemistry, 2012, vol. 49, p. 200 - 210
[8] Advanced Synthesis and Catalysis, 2015, vol. 357, # 5, p. 1013 - 1021
[9] Patent: CN103570683, 2018, B, . Location in patent: Paragraph 0819; 0829-0832
[10] Journal of Organometallic Chemistry, 2018, vol. 868, p. 154 - 163
[11] Bulletin of the Chemical Society of Japan, 1989, vol. 62, # 1, p. 198 - 210
[12] Patent: CN106749407, 2017, A, . Location in patent: Paragraph 0009; 0035; 0036
[13] Journal of Medicinal Chemistry, 1989, vol. 32, # 6, p. 1147 - 1156
[14] Tetrahedron Letters, 1996, vol. 37, # 15, p. 2577 - 2580
[15] European Journal of Medicinal Chemistry, 2011, vol. 46, # 12, p. 5885 - 5893
[16] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 8, p. 2976 - 2979
[17] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 9, p. 3038 - 3048
[18] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 5, p. 1548 - 1552
[19] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 8, p. 2035 - 2039
[20] European Journal of Organic Chemistry, 2016, vol. 2016, # 17, p. 2944 - 2953
[21] ChemMedChem, 2016, vol. 11, # 20, p. 2327 - 2338
  • 2
  • [ 110-52-1 ]
  • [ 1074-82-4 ]
  • [ 5394-18-3 ]
YieldReaction ConditionsOperation in experiment
92% at 115℃; for 15 h; Into a Sovirel type reactor mechanically stirred, provided with a condenser, an opening for introduction of solids, a system for inerting with nitrogen, and a temperature probe, are loaded 5 mol (1081 g) of 1,4-dibromobutane and 1 mol (188 g; 98.5percent pure) of potassium phthalimide. The reaction medium is brought under stirring to 115° C. and then kept at this temperature for 15 h. It is verified that the conversion is complete by a measurement of the potassium bromide in the reaction medium. [0048] After cooling of the reaction medium to 80° C., 200 g of water are added. After 15 min of stirring and then decantation, the aqueous phase containing the potassium bromide is removed and then a second washing is carried out (still at 80° C.) with 50 g of water. [0049] The ascending condenser is then replaced by a distillation column and then the excess 1,4-dibromobutane is distilled under reduced pressure (8-10 mbar) with a bottom temperature from 80 to 120° C. Thus, 815 g of 1,4-dibromobutane are recovered corresponding to a recovery rate of 1,4-dibromobutane of 94percent. This latter with a purity greater than 99.8percent may be directly recycled into a later operation. [0050] At the end of the distillation, the reaction medium is left to cool to 75-80° C. and then 325 g of ethanol are added. After homogenization and obtention of a clear organic solution at reflux of ethanol, the reaction medium is left to cool under stirring to room temperature (20° C.). [0051] After crystallization of the N-(4-bromobutyl)phthalimide, the ethanolic suspension of the product is filtered on frit at room temperature. The moist cake is washed with 35 g of ethanol and then dried at 50° C. under reduced pressure (20 mmHg). Thus, 268 g of N-(4-bromobutyl)phthalimide are obtained that correspond to a molar yield of 92percent compared with the potassium phthalimide provided.
92.4% at 20℃; for 26 h; The phthalimide potassium salt (2.0g, 10 . 7mmol) with 1, 4 - dibromo butane (2.8g, 12 . 9mmol) dissolved in 25 ml dry N,N-dimethylformamide in, for pH 10, room temperature stirring 26h. Dichloromethane is used for extraction three times (100 ml × 3), washed with distilled water, combined with the organic layer, drying by anhydrous magnesium sulphate, concentrated, dichloromethane/distilled water recrystallization, filtering, drying to obtain the white solid, yield of 92.4percent.
85% at 30℃; General procedure: Potassium phthalimide (0.93 g, 5 mmol) was added to a solution of 1,2-dibromoethane (1.3 mL, 15 mmol) in DMF (8 mL). The mixture was stirred at room temperature overnight and evaporated the solvent in vacuo, the residue dissolved in H2O and extracted with ethyl acetate. The organic layer was washed by brine and dried by MgSO4. Filtered and the solvent evaporated in vacuo, recrystallized from ethyl acetate to give white solid (566 mg, 45 percent).
84% With tetrabutylammomium bromide In N,N-dimethyl-formamide at 78℃; for 6 h; Potassium phthalimide (18.62 g, 0.10 mol) and tetrabutylammoniumbromide (TBAB, 5.00 g) were added to a solutionof 1,4-dibromobutane (35.5 mL, 0.30mol) in N, N-Dimethylformamide (DMF, 240 mL) at room temperature and then the mixture was stirred at 78 °C for 6 h. After the completion of the reaction (monitored by TLC analysis), the mixture was filtered, and washed with DMF (20 mL × 2).The filtrate was evaporated under vacuum to removed DMF,the residual liquid was poured into ice-water bath, immediately a large amount of white solid generated. The white solid was collected by filtration, washed on the filter withwater and dried in vacuum. The crude residue was purifiedby recrystallization from methanol to afford pure N-(4-Bromobutyl) phthalimide 2 (23.60 g, 84percent, m.p. 79-81oC aswhite solid. 1H NMR (CDCl3, 400 MHz), δ: 1.82-1.95 (m,4H, C13H, C14H), 3.45 (t, J=6.3 Hz, 2H, C15H), 3.73 (t,J=6.6 Hz, 2H, C16H), 7.27-7.74 (m, 2H, C3H, C6H), 7.83-7.86 (m, 2H, C1H, C2H); 13C NMR (CDCl3, 100 MHz), δ:27.3 (C13), 29.9 (C14), 32.8 (C15), 37.0 (C12), 123.3 (C3,C6), 132.1 (C4, C5), 134.0 (C1, C2), 168.4 (C7, C9). KunHu has reported the same compound in 2013 [17], the NMRcharacterization in the literature is described as follows: 1HNMR (CDCl 3, 500 MHz): d 1.84-1.94 (m, 4H), 3.45 (t,2H, J = 6.0 Hz), 3.73 (t, 2H, J = 6.5 Hz), 7.73 (dd, 2H, J =3.0, 5.5 Hz), 7.85 (dd, 2H, J = 3.0, 5.0 Hz); 13 C NMR(CDCl 3, 125 MHz): d 27.27, 29.89, 32.73, 36.99, 123.27,132.11, 133.99, 168.36.
82.5% With tetrabutylammomium bromide In N,N-dimethyl-formamide at 70℃; for 2 h; 50 mL DMF, 0.025 mol potassium salt of phthalimide,0.10 mol 1,4-dibromobutane and 0.5 g TBAB,70 reaction 2.0h;Cool to room temperature,Pour ice waterEthyl acetate extraction,Washed,dry,De-soluble,Stand overnight,5.82 g of N- (4-bromobutyl) phthalimide precipitated as a white solid,m.p. 78-81 ° C, yield 82.5percent.
82% for 24 h; Reflux General procedure: A mixture of phthalimide10(6.8 mmol) dissolved in EtOH (20 mL) was gently boiled for about 1h. The hot solution was decanted from any solid into 1.25 mL of a specially prepared solution of KOH (15.25 g KOH dissolved in 15 mL of H2O and 45 mL of EtOH). A precipitate of potassium phthalimide separates at once. The mixture was stirred and cooled quickly to room temperature, and the precipitate was filtered under vacuum. To the alcoholic mother liquors a second 1 g portion of phthalimide was added, and the entire process was repeated. The two crops of crystals were united and washed with acetone to remove any unchanged phthalimide. After air-dried pure potassium phthalimidewas obtained as white crystals (yield 30percent). In a second step, a mixture of potassium phthalimide (2.2 mmol),the appropriate dibromoalkane derivative (2.9 mmol) and 2.5 mL of acetone was stirred and refluxed for 24h, and then cooled to 15 °C. After filtering off the precipitated potassium bromide, the cake was washed with acetone and the solvent evaporated to give pure compound.
82.5% With tetrabutylammomium bromide In N,N-dimethyl-formamide at 70℃; for 2 h; 50 mL of DMF, 0.025 mol of the potassium salt of phthalimide, 0.10 mol of 1,4-dibromobutane and 0.5 g of TBAB, reaction at 70° C. for 2.0 h; cooling to room temperature, pouring into ice water, extraction with ethyl acetate, After washing with water, drying and desolvation, the mixture was allowed to stand overnight to precipitate 5.82 g of N-(4-bromobutyl)phthalimide as a white solid, mp 78-81°C, yield 82.5percent.
78.2% With potassium carbonate In acetone at 60 - 65℃; Inert atmosphere General procedure: The appropriate dibromoalkane derivative 2a-2e (11.9 mmol) was added slowly to a mixture of the starting material phthalimide potassium salt (1) (1g, 5.4 mmol) and anhydrous K2CO3 (0.82 g, 5.94 mmol) in acetone (15 mL). The reaction mixture was heated to 60-65 °C and stirred for 6-10 h under an argon atmosphere. After complete reaction, the solvent was evaporated under reduced pressure. Water (50 mL) was added to the residue and the mixture was extracted with dichloromethane (30 mL × 3). The combined organic phases were washed with saturated aqueous NaCl, dried over Na2SO4, and filtered. The solvent was evaporated to dryness under reduced pressure. The crude product was purified on a silica gel chromatography using dichloromethane/acetone (50:1) as eluent to give the intermediates 3a-3e.
76% With potassium carbonate; potassium iodide In acetone at 100℃; for 6 h; General procedure: To a solution of 1.6g (10.0mmol) of (R,S) 4-phenyloxazolin-2-one (13), 3.4g (25.0mmol) of K2CO3 and a catalytic amount of KI in acetonitrile, 5.4g (25.0mmol) of 1,4-dibromobutane were slowly added drop by drop stirring at rt. The mixture was then heated under reflux for 6–12h, monitored by TLC (CH2Cl2/EtOH 9:1). The hot solution was filtered and evaporated under reduced pressure. The yellow oil residue of (R,S) 3-(4-bromobutyl)-4-phenyloxazolidin-2-one 23 was used without further purification. (0045) Yield: 96percent;
75% for 10.25 h; Reflux General procedure: Acetone (150mL) and dibromoalkyl (30mol) were added to a 250mL three-necked round-bottom flask fitted with a mechanical stirrer and reflux condenser. Potassium phthalimide (11.85g, 10 mol) was added slowly over a 15-min period, and then the reaction mixture was heated under reflux for 10h. The reaction mixture was filtered via suction, and the acetone was removed via rotary evaporation. The crude product was purified by flash chromatography on silica gel (EtOAc:petroleum ether=1:14) to afford 2–5 as white solid.
72.3% at 90℃; for 18.5 h; To a stirred solution of 1,4-dibromobutane (2j) (9,7 mL, 27,0 mmoi) (100 mL), was added potassIum phthaiate (i—) (5.0 g, 27,0 mrnol) portion—wise over 30 mm at room temperature. After complete addition, the reaction mixture was stirred at 90 °C for 18 h, then quenched with water (300 rnL) and extracted with diethyl ether (150 mL x 2). The combined organic extracts were washed with water (100 mL x 2), followed by brine (50 rnL x 2) and dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to obtain the crude. The crude product was purified by silica gel column chromatography (60- 120 mesh) using 5.40percent EtOAc / hexanes to afford 3j as an off- white solid (5.5 g, 72.3percent yield). LCMS: 2.3.9(M+1)
72.3% at 20 - 90℃; for 18.5 h; To a stirred solution of 1,4-dibromobutane (2-j) (9.7 mL, 27.0 mmol) in DMF (100 mL), was added potassium phthalate (1-j) (5.0 g, 27.0 mmol) portion-wise over 30 min at room temperature. After complete addition, the reaction mixture was stirred at 90 °C for 18 h, then quenched with water (300 mL) and extracted with diethyl ether (150 mL x 2). The combined organic extracts were washed with water (100 mL x 2), followed by brine (50 mL x 2) and dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to obtain the crude. The crude product was purified by silica gel column chromatography (60- 120 mesh) using 5-10percent EtOAc / hexanes to afford 3-j as an off- white solid (5.5 g, 72.3percent yield). LCMS: 283.9(M+1).
72.3% at 20 - 90℃; for 18.5 h; To a stirred solution of 1,4-dibromobutane (2-j) (9.7 mL, 27.0 mmol) in DMF (100 mL), was added potassium phthalate (1-j) (5.0 g, 27.0 mmol) portion-wise over 30 mm at room temperature. After complete addition, the reaction mixture was stirred at 90 °C for 18 h, then quenched with water (300 mL) and extracted with diethyl ether (150 mL x 2). The combined organic extracts were washed with water (100 mL x 2), followed by brine (50 mL x 2) and dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to obtain the crude. The crude product was purified by silica gel column chromatography (60- 120 mesh) using 5-10percent EtOAc / hexanes to afford 3-j as an off- white solid (5.5 g, 72.3percent yield). LCMS: 283.9(M+1).
72.3% at 90℃; for 18 h; To a stirred solution of 1,4-dibromobutane (2-j) (9.7 mL, 27.0 mmol) in DMF (100 mL), was added potassium phthalate (1-j) (5.0 g, 27.0 mmol) portion-wise over 30 min at room temperature. After complete addition, the reaction mixture was stirred at 90 °C for 18 h, then quenched with water (300 mL) and extracted with diethyl ether (150 mL x 2). The combined organic extracts were washed with water (100 mL x 2), followed by brine (50 mL x 2) and dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to obtain the crude. The crude product was purified by silica gel column chromatography (60- 120 mesh) using 5-10percent EtOAc / hexanes to afford 3-j as an off- white solid (5.5 g, 72.3percent yield). LCMS: 283.9(M+1).
72.3% at 20 - 90℃; for 18.5 h; To a stirred solution of 1,4-dibromobutane (2-j) (9.7 mL, 27.0 mmol) in DMF (100 mL), was added potassium phthalate (1-j) (5.0 g, 27.0 mmol) portion-wise over 30 mm at room temperature. After complete addition, the reaction mixture was stirred at 90 °C for 18 h, then quenched with water (300 mL) and extracted with diethyl ether (150 mL x 2). The combined organic extracts were washed with water (100 mL x 2), followed by brine (50 mL x 2) and dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to obtain the crude. The crude product was purified by silica gel column chromatography (60- 120 mesh) using 5-10percent EtOAc / hexanes to afford 3-j as an off- white solid (5.5 g, 72.3percent yield). LCMS: 283.9(M+1).
72.3% at 20 - 90℃; Production Example 25a: Synthesis of (R)-N-(1-(3-(cyclopropylmethoxy)-4- fluorophenyl) ethyl)-4-(2,4-dioxoimidazolidin-1-yl)butane-1-sulfonamideScheme 11. [0697] Step 1: Synthesis of 2-(4-bromobutyl)isoindoline-1,3-dione (3-j) To a stirred solution of 1,4-dibromobutane (2-j) (9.7 mL, 27.0 mmol) in DMF (100 mL), was added potassium phthalate (1-j) (5.0 g, 27.0 mmol) portion-wise over 30 min at room temperature. After complete addition, the reaction mixture was stirred at 90 °C for 18 h, then quenched with water (300 mL) and extracted with diethyl ether (150 mL x 2). The combined organic extracts were washed with water (100 mL x 2), followed by brine (50 mL x 2) and dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to obtain the crude. The crude product was purified by silica gel column chromatography (60- 120 mesh) using 5-10percent EtOAc / hexanes to afford 3-j as an off- white solid (5.5 g, 72.3percent yield). LCMS: 283.9(M+1).
68.3% With potassium carbonate In acetoneReflux General procedure: A mixture of dibromoalkane (23 mmol) and potassium carbonate (12 mmol)was added in acetone (30 mL), and potassium phthalimide (10 mmol) was added slowly over a 15-min period, and then the reaction was heated under reflux for 8-10 h. The reaction mixture was filtered,and the acetone was evaporated in vacuo. The crude product was purified by column chromatography on silica gel using mixtures of petroleum/acetone as eluent) to obtain the white solid compounds 2-4.
66% at 0 - 20℃; for 18 h; Syntheses of D,L-Sulforaphane and Erysolin; Compound 9; 2-(4-bromobutyl)isoindoline-l,3-dione; The following procedure was adapted from that previously reported by Vermeulen, et al (25) 1 ,4-Dibromobutane (4 400 mL, 36 457 mmols) was dissolved in anhydrous DMF (52 mL) and the resulting solution was chilled to 0°C under argon After 15 min, potassium phthahmide (3 459 g, 18 672 mmols) was slowly added to the stirring solution and the reaction was allowed to warm to ambient temperature under argon over 18 h The reaction was concentrated in vacuo and co-stπpped with anhydrous THF several times Products were dissolved in 1 1 H2O EtOAc (200 mL) and the aqueous phase was extracted with EtOAc (3 x 100 mL) Combined organics were washed with brine, dried over Na2SO4, and filtered through a celite plug prior to concentration in vacuo Silica gel chromatography (3 1 Hexane EtOAc) and subsequent concentration afforded 3 466 g 9 as a white solid (66percent yield) 1H NMR (CDCl3) 5 7 85 (dd, J = 5 4, 3 1 Hz, 2H), 7 73 (dd, J = 5 4, 3 0 Hz, 2H), 3 73 (t, J = 6 7 Hz, 2H), 3 45 (t, J = 6 4 Hz, 2H), 1 89 (m, 4H) 13C NMR (CDCl3) δ 168 5, 134 1, 132 2, 123 4, 37 1, 32 9, 30 0, 27 4 HRMS (ESI-EMM) calc'd for [M + Na]+ m/z 303 9949, found 303 9936
66% at 0 - 20℃; for 18 h; Inert atmosphere Compound 9: 2-(4-bromobutyl)isoindoline-1,3-dione. The following procedure was adapted from that previously reported by Vermeulen, et al. (25). 1,4-Dibromobutane (4.400 mL, 36.457 mmols) was dissolved in anhydrous DMF (52 mL) and the resulting solution was chilled to 0° C. under argon. After 15 min, potassium phthalimide (3.459 g, 18.672 mmols) was slowly added to the stirring solution and the reaction was allowed to warm to ambient temperature under argon over 18 h. The reaction was concentrated in vacuo and co-stripped with anhydrous THF several times. Products were dissolved in 1:1 H2O:EtOAc (200 mL) and the aqueous phase was extracted with EtOAc (3×100 mL). Combined organics were washed with brine, dried over Na2SO4, and filtered through a celite plug prior to concentration in vacuo. Silica gel chromatography (3:1 Hexane:EtOAc) and subsequent concentration afforded 3.466 g 9 as a white solid (66percent yield). 1H NMR (CDCl3) δ 7.85 (dd, J=5.4, 3.1 Hz, 2H), 7.73 (dd, J=5.4, 3.0 Hz, 2H), 3.73 (t, J=6.7 Hz, 2H), 3.45 (t, J=6.4 Hz, 2H), 1.89 (m, 4H). 13C NMR (CDCl3) δ 168.5, 134.1, 132.2, 123.4, 37.1, 32.9, 30.0, 27.4. HRMS (ESI-EMM) calc'd for [M+Na]+m/z 303.9949. found 303.9936.
61% at 115 - 120℃; for 12 h; Into a Sovirel type reactor mechanically stirred, provided with a condenser, an opening for introduction of solids, a system inerting with nitrogen, and a temperature probe, are loaded 655 g of 1,4-dibromobutane at 99percent purity (3 mol) and 187 g of potassium phthalimide at 99percent purity (1 mol). The reaction medium is brought under stirring between 115° C. and 120° C. and then kept at this temperature for 12 h. It is verified that the transformation of potassium phthalimide is completed by a measurement of the KBr in the reaction medium and then the excess 1,4-dibromobutane is evaporated under reduced pressure (10 to 18 mmHg). The recovery rate of the 1,4-dibromobutane is near 90percent and this latter may be recycled directly into a later operation. [0052] At the end of the distillation, the heterogeneous reaction medium is 120° C.-130° C. Its temperature is lowered to 70° C. and then 320 g of ethanol are introduced. The medium is kept at 70° C. [0053] The contents of the reactor are filtered at 70° C. on a frit kept at this temperature. The moist cake is dried. It essentially contains KBr and diphthalimidobutane. [0054] The ethanolic filtrate is left to cool to 20° C., which causes crystallization of the N-(4-bromobutyl)phthalimide. The ethanolic suspension of the product is filtered on the frit. The moist cake is washed with 2 ethanol fractions and then dried at 50° C. under reduced pressure (20 to 30 mmHg). Thus, 173 g of N-(4-bromobutyl)phthalimide are obtained or an isolated yield of 61percent compared with the potassium phthalimide provided.
61% for 12 h; Heating / reflux Potassium phthalimide (65 g, 350 mmol, 1.00 eq.) and tetramethylene dibromide (200 g, 930 mmol, 2.66 eq.) were combined (neat) and heated for 12 hours. The excess tetramethylene dibromide was removed via rotary-evaporation (rotovap). The resulting residue was digested with ethanol and filtered. The material that crystallized on standing was filtered, washed with ethanol, and dried in vacuo. A second crop was obtained by concentration of combined filtrate and washings. The combined mass of crops was 60.5 g (61percent yield).
48.6% With tetra-(n-butyl)ammonium iodide In acetone for 18 h; Reflux (3)
N-(4-bromobutyl)phthalimide
93.6g (0.43mol) 1,4-dibromobutane was weighed, and added to 380mL acetone.
The mixture was added with 72.5g (0.39mol) phthalimide potassium salt and 2.1g tetrabutylammonium iodide under stirring, subjected to refluxing for 18h, cooled, filtrated to remove solid, and washed with acetone.
All acetone solutions are combined, subjected to recovering the solvent under a reduced pressure, and added with petroleum ether for crystallization while the reaction mixture was hot.
A solid was filtered out, washed with with petroleum ether and dried to obtain a product 48.0g(43.6percent),mp 75∼78°C.
The mother liquor was concentraed to precipitate crystal, cooled in an ice-bath to obtain a solid 5.5g (5.0percent), mp 73∼76°C.
48.6% With tetra-(n-butyl)ammonium iodide In acetone for 18 h; Reflux (3)
N-(4-bromobutyl)phthalimide
93.6 g (0.43 mol) 1,4-dibromobutane was weighed, and added to 380 mL acetone.
The mixture was added with 72.5 g (0.39 mol) phthalimide potassium salt and 2.1 g tetrabutylammonium iodide under stirring, subjected to refluxing for 18 h, cooled, filtrated to remove solid, and washed with acetone.
All acetone solutions are combined, subjected to recovering the solvent under a reduced pressure, and added with petroleum ether for crystallization while the reaction mixture was hot.
A solid was filtered out, washed with petroleum ether and dried to obtain a product 48.0 g (43.6percent), mp 75~78° C.
The mother liquor was concentrated to precipitate crystal, cooled in an ice-bath to obtain a solid 5.5 g (5.0percent), mp 73~76° C.
17.3 g at 20℃; for 48 h; A mixture of 1,4-dibromobutane (22 mL, 185 mmol) and potassium phthalimide (11.35 g, 61.4 mmol) in 60 mL of DMF was mixed at room temperature for 1 day. Then, the reaction mixture was extracted with hexane (3x150 mL). The hexane fractions were dried over MgS04, filtered, and concentrated to give 30 g of a 1:2.2 molar mixture of recovered 1,4-dibromobutane and DMF. This mixture was diluted with 30 mL of DMF and retreated with potassium phthalimide (4.80 g, 26 mmol) at room temperature for 1 day. The two reaction mixtures in DMF were partitioned between 1: 1 EA/Hex (3x150 mL) and H20 (2x100 mL), 0.1M HCl (100 mL), and brine (100 mL).The organic phases were dried over MgS04 and concentrated. SPE, eluting with 0percent and 10percent EA/Hex, gave 17.3 g of colorless solid. R 0.55 (40percent EA/Hex); 1H NMR (CDC13) δ 7.86-7.81 (m, 2H), 7.73-7.69 (m, 2H), 3.71 (t, 2H), 3.43 (t, 2H), 1.94-1.80 (m, 4H); 13C NMR (CDC13) δ 168.5, 134.2, 132.3, 123.5, 37.2, 32.9, 30.1, 27.4.
5.6 g at 20℃; for 15 h; 7.8ml (6. 5 X 10 2 mol) of 1,4-dibromobutane with 6 g (3. 2 X 10 2 moles) Phthalimide potassium salt dissolved in 100ml of N, N- dimethylformamide andunder room temperatureit was stirred for 15hours.The solvent was distilled off under reduced pressure The residue usingn-hexane: ethyl acetate with a volumeratio of 10: 1 eluent to carry out column chromatography, gradually increasingthe polarity to hexane: ethyl acetate with a volume ratio of 5: 1 to give aproduct of 5.6g (2.0X102mole) a bromo group substituted by Phthalimide. The product with 5. 0g (5. 0X 10 2 mol) ofsodium sulfite, 140ml water and 85ml95percent ethanol mixed reaction was heated to 95° C for 18h, the remaining solvent was drained, and the resulting residue was mixed with 73ml ofconcentrated hydrochloric acid then was heated to 110 ° C the for 18H, itwas drained, with water - 95percent ethanol on the residue to carry out recrystallization to give 2. 5g of4-amino-1-Butanesulfonic acid (total yield 50percent).

Reference: [1] Patent: US2004/176613, 2004, A1, . Location in patent: Page 3
[2] ACS Medicinal Chemistry Letters, 2016, vol. 7, # 3, p. 245 - 249
[3] Patent: CN104910894, 2017, B, . Location in patent: Paragraph 0032; 0034; 0042; 0043
[4] Organic Letters, 2011, vol. 13, # 4, p. 764 - 767
[5] Chinese Chemical Letters, 2016, vol. 27, # 2, p. 185 - 189
[6] Letters in Organic Chemistry, 2018, vol. 15, # 3, p. 206 - 213
[7] Patent: CN107382980, 2017, A, . Location in patent: Paragraph 0041; 0042; 0043; 0044
[8] European Journal of Medicinal Chemistry, 2018, vol. 149, p. 69 - 78
[9] Patent: CN107540647, 2018, A, . Location in patent: Paragraph 0056-0059
[10] Angewandte Chemie, International Edition, 2009, vol. 48, # 36, p. 6675 - 6677[11] Angewandte Chemie, 2009, vol. 121, # 36, p. 6803 - 6805
[12] Archiv der Pharmazie, 2012, vol. 345, # 7, p. 509 - 516
[13] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 22, p. 5053 - 5059
[14] European Journal of Medicinal Chemistry, 2016, vol. 121, p. 712 - 726
[15] European Journal of Medicinal Chemistry, 2013, vol. 64, p. 529 - 539
[16] Chemistry and Biodiversity, 2013, vol. 10, # 12, p. 2247 - 2266
[17] Patent: WO2017/6282, 2017, A1, . Location in patent: Paragraph 0649
[18] Patent: WO2018/98208, 2018, A1, . Location in patent: Paragraph 0633
[19] Patent: WO2018/98204, 2018, A1, . Location in patent: Paragraph 0722
[20] Patent: WO2018/98206, 2018, A1, . Location in patent: Paragraph 0738
[21] Patent: WO2018/98207, 2018, A1, . Location in patent: Paragraph 0731
[22] Patent: WO2018/128720, 2018, A1, . Location in patent: Paragraph 0697
[23] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 10, p. 2539 - 2543
[24] Patent: WO2008/8954, 2008, A2, . Location in patent: Page/Page column 22
[25] Patent: US2013/116203, 2013, A1, . Location in patent: Paragraph 088
[26] Patent: US2004/176612, 2004, A1, . Location in patent: Page 3
[27] Patent: US2008/176942, 2008, A1, . Location in patent: Page/Page column 8
[28] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1985, p. 511 - 518
[29] Patent: EP2354136, 2011, A1, . Location in patent: Page/Page column 13
[30] Patent: US2011/319423, 2011, A1, . Location in patent: Page/Page column 8
[31] Helvetica Chimica Acta, 1980, vol. 63, # 7, p. 2112 - 2118
[32] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1985, p. 191 - 196
[33] Journal of the American Chemical Society, 1949, vol. 71, p. 554,560
[34] Journal of the American Chemical Society, 1954, vol. 76, p. 2414,2417
[35] Journal of Organic Chemistry, 1951, vol. 16, p. 708,710
[36] Bulletin de la Societe Chimique de France, 1938, vol. <5>5, p. 871,875
[37] Journal of the American Chemical Society, 1981, vol. 103, # 26, p. 7773 - 7779
[38] Monatshefte fuer Chemie, 1981, vol. 112, p. 825 - 840
[39] European Journal of Medicinal Chemistry, 2003, vol. 38, # 7-8, p. 729 - 737
[40] Chemosphere, 2004, vol. 57, # 8, p. 975 - 985
[41] Journal of Materials Chemistry, 2006, vol. 16, # 4, p. 351 - 358
[42] Journal of Medicinal Chemistry, 2002, vol. 45, # 5, p. 1128 - 1141
[43] European Journal of Organic Chemistry, 2000, # 4, p. 665 - 673
[44] Organic Preparations and Procedures International, 2008, vol. 40, # 5, p. 499 - 504
[45] Science China Chemistry, 2011, vol. 54, # 7, p. 1148 - 1154
[46] Journal of Medicinal Chemistry, 2012, vol. 55, # 5, p. 1910 - 1919
[47] Patent: WO2014/120995, 2014, A2, . Location in patent: Page/Page column 88
[48] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 7, p. 1629 - 1637
[49] Archiv der Pharmazie, 2015, vol. 348, # 8, p. 556 - 563
[50] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 9, p. 2380 - 2382
[51] European Journal of Medicinal Chemistry, 2016, vol. 122, p. 17 - 26
[52] Patent: CN101948412, 2016, B, . Location in patent: Paragraph 0031; 0032
[53] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 16, p. 3464 - 3471
[54] Patent: CN103833623, 2016, B, . Location in patent: Paragraph 0058; 0059; 0061
[55] Patent: US2018/193330, 2018, A1, . Location in patent: Paragraph 0011; 0140
  • 3
  • [ 110-52-1 ]
  • [ 33081-78-6 ]
  • [ 5394-18-3 ]
YieldReaction ConditionsOperation in experiment
68.3% With potassium carbonate In acetoneReflux General procedure: To a suspension of the appropriate dibromoalkane (33mmol) and potassium carbonate (18mmol) in anhydrous acetone (30mL), and potassium phthalimide (15mmol) was added slowly over a 15min period, and then the reaction mixture was heated under reflux for 8–10h. The reaction mixture was filtered, and the acetone was evaporated in vacuo. The crude product was purified by column chromatography on silica gel (petroleum/acetone as eluent) to obtain 2a-d as white solid.#10;#10;
Reference: [1] European Journal of Medicinal Chemistry, 2017, vol. 135, p. 307 - 323
  • 4
  • [ 24697-70-9 ]
  • [ 5394-18-3 ]
Reference: [1] Patent: WO2011/121055, 2011, A1, . Location in patent: Page/Page column 24
  • 5
  • [ 62168-25-6 ]
  • [ 1074-82-4 ]
  • [ 5394-18-3 ]
YieldReaction ConditionsOperation in experiment
58% With sodium hydrogencarbonate In <i>N</i>-methyl-acetamide; hexane; water EXAMPLE 81
2-(4-Bromo-butyl)-isoindole-1,3-dione
To a hot solution (90° C.) of dibromobutane (1.50 kg, 6.95 mol) in dimethylformamide (1.7 L) was added potassium phthalimide (329 g, 1.74 mol).
The solution was stirred at 90° C. for 5 hours.
The solution was cooled to room temperature prior to the addition of water (900 mL).
The layers were separated and the aqueous layer was extracted with CH2Cl2 (2*500 mL).
The combined organic portions were washed with a saturated aqueous solution of NaHCO3 (1.0 L).
The organic layer was dried (MgSO4) and concentrated under reduced pressure.
Hexane (3.0 L) was added to the residue and the solid (mostly diphthalimide side product) was filtered.
Hexane (1.0 L) was added to the filtrate and the resulting mixture was placed at -20° C. for 1.5 hours. the precipitate was filtered and dried under vacuum to afford 285 g (58percent) of 2-(4-bromo-butyl)-isoindole-1,3-dione as white solid. 1H NMR (CDCl3) δ 1.75-7.95 (m, 4H), 3.44 (t, 2H, J=6.5 Hz), 3.71 (t, 2H, J=6.5 Hz), 7.65-7.75 (m, 2H), 7.80-7.90 (m, 2H).
13C NMR (CDCl3) δ 27.64, 30.22, 33.26, 37.35, 123.68, 132.42, 134.42, 168.79.
Reference: [1] Patent: US2005/154201, 2005, A1,
  • 6
  • [ 85-44-9 ]
  • [ 40898-95-1 ]
  • [ 5394-18-3 ]
Reference: [1] Patent: US5610195, 1997, A,
  • 7
  • [ 136918-14-4 ]
  • [ 5394-18-3 ]
Reference: [1] Organic Letters, 2011, vol. 13, # 4, p. 764 - 767
[2] Patent: CN103833623, 2016, B,
[3] Patent: CN107382980, 2017, A,
[4] European Journal of Medicinal Chemistry, 2018, vol. 149, p. 69 - 78
[5] Patent: CN107540647, 2018, A,
  • 8
  • [ 110-52-1 ]
  • [ 3481-09-2 ]
  • [ 5394-18-3 ]
Reference: [1] RSC Advances, 2015, vol. 5, # 80, p. 65600 - 65603
  • 9
  • [ 110-52-1 ]
  • [ 136918-14-4 ]
  • [ 5394-18-3 ]
  • [ 3623-90-3 ]
Reference: [1] Russian Journal of Applied Chemistry, 2000, vol. 73, # 12, p. 2106 - 2108
[2] Helvetica Chimica Acta, 1948, vol. 31, p. 1497,1500
[3] Journal of the Chemical Society, 1952, p. 3334,3337
  • 10
  • [ 85-44-9 ]
  • [ 5394-18-3 ]
Reference: [1] Patent: WO2011/121055, 2011, A1,
  • 11
  • [ 5394-18-3 ]
  • [ 87789-49-9 ]
  • [ 88-96-0 ]
Reference: [1] Patent: US6284759, 2001, B1,
  • 12
  • [ 5394-18-3 ]
  • [ 23195-62-2 ]
Reference: [1] Patent: US5635485, 1997, A,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 5394-18-3 ]

Bromides

Chemical Structure| 17702-83-9

[ 17702-83-9 ]

2-(8-Bromooctyl)isoindoline-1,3-dione

Similarity: 0.98

Chemical Structure| 954-81-4

[ 954-81-4 ]

N-(5-Bromopentyl)phthalimide

Similarity: 0.98

Chemical Structure| 5460-29-7

[ 5460-29-7 ]

N-(3-Bromopropyl)phthalimide

Similarity: 0.94

Chemical Structure| 111992-61-1

[ 111992-61-1 ]

2-(3-Bromo-2,2-dimethylpropyl)isoindoline-1,3-dione

Similarity: 0.89

Chemical Structure| 5332-26-3

[ 5332-26-3 ]

2-(Bromomethyl)isoindoline-1,3-dione

Similarity: 0.87

Amides

Chemical Structure| 17702-83-9

[ 17702-83-9 ]

2-(8-Bromooctyl)isoindoline-1,3-dione

Similarity: 0.98

Chemical Structure| 954-81-4

[ 954-81-4 ]

N-(5-Bromopentyl)phthalimide

Similarity: 0.98

Chemical Structure| 5460-29-7

[ 5460-29-7 ]

N-(3-Bromopropyl)phthalimide

Similarity: 0.94

Chemical Structure| 550-44-7

[ 550-44-7 ]

2-Methylisoindoline-1,3-dione

Similarity: 0.90

Chemical Structure| 5428-09-1

[ 5428-09-1 ]

2-Allylisoindoline-1,3-dione

Similarity: 0.90

Related Parent Nucleus of
[ 5394-18-3 ]

Indolines

Chemical Structure| 17702-83-9

[ 17702-83-9 ]

2-(8-Bromooctyl)isoindoline-1,3-dione

Similarity: 0.98

Chemical Structure| 954-81-4

[ 954-81-4 ]

N-(5-Bromopentyl)phthalimide

Similarity: 0.98

Chemical Structure| 5460-29-7

[ 5460-29-7 ]

N-(3-Bromopropyl)phthalimide

Similarity: 0.94

Chemical Structure| 550-44-7

[ 550-44-7 ]

2-Methylisoindoline-1,3-dione

Similarity: 0.90

Chemical Structure| 5428-09-1

[ 5428-09-1 ]

2-Allylisoindoline-1,3-dione

Similarity: 0.90